Drug profile · INN
hexafluorenium bromide
MYLAXEN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
hexafluorenium bromide (MYLAXEN) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN hexafluorenium bromide
Brand MYLAXEN
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is hexafluorenium bromide?
hexafluorenium bromide (MYLAXEN) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for hexafluorenium bromide?
MYLAXEN is a marketed brand name for hexafluorenium bromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hexafluorenium bromide?
hexafluorenium bromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.